EDGE
Get a demo
Log In

AI Therapeutics

AI Drug Discovery
Segments:
AI Drug Discovery & Development
?
Product stage:
Early
?

AI Therapeutics (formerly LAM Therapeutics) is a biotechnology company that has developed an artificial intelligence (AI) drug development platform to find therapeutics. Its AI and deep learning platform, Guardian Angel, use public and proprietary data on drugs and diseases to find new drug candidates.

AI Therapeutics has advanced four drugs into clinical trials targeting a rare lung disease, a rare neurological disease, cancer in the lymphatic system, acute myeloid leukemia (a type of blood cancer), and facial angiofibroma. Its platform identified that out of these, one drug candidate can also be used for Covid-19, which is currently at the clinical trial Phase II stage. The company is seeking collaboration partners to commercialize these drugs. AI Therapeutics, a part of 4Catalyzer (a startup accelerator), closed USD 58 million in Series C financing in March 2017.

AI Drug Discovery

AI Drug Discovery

Key stats
Featured companies
158
Total funding (USD)
25.1 Bn
Total addressable market (USD)
39.6 Bn
Key competitors
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

Recent Updates

Product updates
Apr 5, 2023
AI Therapeutics announces positive results from Phase IIa clinical trial
AI Drug Discovery

Company Brief


HQ location:
530 Old Whitfield Street Guilford CT USA
Founded year:
2013
Employees:
101-250
Total Funding:
USD 98.0 million
Last Funding
USD 58.0 million, Mar 2017

Funding


Investors


No investor data is available

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.